Novo Nordisk filed for approval of an oral, 25-mg formulation of its weight loss blockbuster “earlier this year,” according ...

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

For those looking to jumpstart their weight journey or finally reach their fitness goals, one option that is the center of ...

there could be other branded oral weight loss drugs available, including a melt-on-the-tongue version of semaglutide, from Canadian firm BioNxt solutions, and ordinary tablets of a drug called ...

Eli Lilly shares jumped 15% after a clinical trial of its experimental pill showed ... the higher-dose weight-loss variant Wegovy, slipped 3.9% amid concerns that a viable oral competitor could ...

Semaglutide is the active ingredient in Novo Nordisk A/S’ (NYSE:NVO) Ozempic and Wegovy, which are available for diabetes and weight loss. In an ongoing study in healthy rats, a single ...

Single dose of Vivani’s NPM-139 semaglutide implant led to nearly 20% weight loss in rats, suggesting once- or twice-yearly dosing. NPM-139 showed steady semaglutide release with potential for ...